Venture Philanthropy - Translational Research
39 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by matthew kapp
Scoop.it!

Bryan Appleyard » Blog Archive » The End of Progress

Bryan Appleyard » Blog Archive » The End of Progress | Venture Philanthropy - Translational Research | Scoop.it
"The end of the world has been promised by Jews, Christians, Muslims and assorted crazies with sandwich boards in Oxford Street for as long as there has been a human world to end. But those doomsdays were the product of faith; reason always used to say the world would continue, that humans would survive......The point about the new apocalypse is that this situation has reversed. Now faith tells us we will be able to solve our problems; reason says we have no answers now and none are likely in the future. Indeed, reason says the more we know, the more we discover what we cannot know. Perhaps we can’t cure cancer because the problem is simply beyond our intellects. Perhaps we haven’t flown to the stars because our biology and God’s physics mean we never can. Perhaps we are close to the limit and the time of plenty is over. The evidence is mounting that our two sunny centuries of growth and wealth may end in a new Dark Ages in which ignorance will replace knowledge, war will replace peace, sickness will replace health and famine will replace obesity."
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Reinvent Risk and Reward

Reinvent Risk and Reward | Venture Philanthropy - Translational Research | Scoop.it
Mariana Mazzucato has a brilliant idea about how America could resuscitate large investments in next-generation technologies and help cultivate future industries for a robust 21st-century economy.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Social enterprise today: Monday 18 November - The Guardian

Social enterprise today: Monday 18 November - The Guardian | Venture Philanthropy - Translational Research | Scoop.it
The Guardian Social enterprise today: Monday 18 November The Guardian Today is the launch of our much anticipated 50 voices project - where we asked 50 individuals involved in or inspired by the sector to share their thoughts on what social...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Former Titans LB Frank Chamberlin Loses Battle to Brain Cancer at 35 - Titansonline.com

Former Titans LB Frank Chamberlin Loses Battle to Brain Cancer at 35 - Titansonline.com | Venture Philanthropy - Translational Research | Scoop.it
Titansonline.com Former Titans LB Frank Chamberlin Loses Battle to Brain Cancer at 35 Titansonline.com Chamberlin was diagnosed with a very serious form of brain cancer last January after collapsing at work with a seizure.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Value of venture philanthropy funds increases to £2.8 billion, says Factary - UK Fundraising

Value of venture philanthropy funds increases to £2.8 billion, says Factary - UK Fundraising | Venture Philanthropy - Translational Research | Scoop.it
Value of venture philanthropy funds increases to £2.8 billion, says Factary UK Fundraising Philanthropy research specialists The Factary report that the UK's venture philanthropy sector has more than doubled in value to charities in two years.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Our Backwards Government Can't Keep Up With the Fast and Furious Germs of the Future | Wired Opinion | Wired.com

Our Backwards Government Can't Keep Up With the Fast and Furious Germs of the Future | Wired Opinion | Wired.com | Venture Philanthropy - Translational Research | Scoop.it
Washington’s paymasters are systematically biased in favor of the drug licensed decades ago. Their principal concern is who should pay how much for the new, patented drug, or whether the old, cheaper generic might do as well.
matthew kapp's insight:
from The Cure In The Code: How 20th Century Law Is Undermining 21st Century Medicine, on the potential life-saving synergy of the digital and biochemical revolutions
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Brain tumor survivor and Northbrook CEO invests to treat others - Northbrook Star

Brain tumor survivor and Northbrook CEO invests to treat others - Northbrook Star | Venture Philanthropy - Translational Research | Scoop.it
Brain tumor survivor and Northbrook CEO invests to treat others Northbrook Star So, still healing, he helped found the Northwestern Brain Tumor Institute as an entity that worked like his vision.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

eTMF Standards Initiative for Clinical Trial Data Exchange Gains Support - PR Web (press release)

eTMF Standards Initiative for Clinical Trial Data Exchange Gains Support - PR Web (press release) | Venture Philanthropy - Translational Research | Scoop.it
eTMF Standards Initiative for Clinical Trial Data Exchange Gains Support PR Web (press release) CareLex, a nonprofit organization for BioInformatics research, today announced growing support for the development of an Electronic Trial Master File...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

T-DM1 Extends PFS in Heavily Pretreated Advanced Breast Cancer

T-DM1 Extends PFS in Heavily Pretreated Advanced Breast Cancer | Venture Philanthropy - Translational Research | Scoop.it
"T-DM1 (ado-trastuzumab emtansine; Kadcyla) extended progression-free survival (PFS) compared with “physician’s choice of treatment” in women with metastatic HER2-positive breast cancer, according to primary results from the TH3RESA trial reported at the 2013 European Cancer Congress. All the women in the trial had progressed on two or more previous HER2-directed treatments, including trastuzumab (Herceptin) and lapatinib (Tykerb). An interim analysis of overall survival (OS) suggests that T-DM1 may have a survival benefit in this setting, but longer follow-up is needed. Previously, the EMILIA trial showed improved median PFS and OS with T-DM1 versus capecitabine (Xeloda) and lapatinib in women with HER2-positive metastatic breast cancer previously treated with a taxane and trastuzumab. TH3RESA is the first phase III trial to evaluate T-DM1 in patients previously treated with at least two HER2-specific therapies, explained the first author of the late-breaking presentation, Hans Wildiers, MD, PhD, University Hospital Leuven, Gasthuisberg, Belgium. “T-DM1 demonstrated improved safety and efficacy compared with the physician’s choice of [therapy]. T-DM1 achieved a significant improvement in PFS, and the effect was clear and consistent across subgroups. These data affirm the results of EMILIA, demonstrating a consistent PFS benefit of T-DM1 in patients with previously treated HER2-positive advanced breast cancer. T-DM1 should become the new standard of care [in this setting],” Wildiers said."
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Is Entrepreneurship With A Social Mission More Successful?

Is Entrepreneurship With A Social Mission More Successful? | Venture Philanthropy - Translational Research | Scoop.it
Is Entrepreneurship With A Social Mission More Successful? - Bangalore: The very first thought that would strike an aspiring entrepreneur would be whether to mix the essence...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

The Social Innovation Fund: Catalyzing Resources for Greater Social Impact

More impact is being generated in low-income communities across the country by philanthropic approaches that are directing resources to grow effective commun...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

We Need Our Brightest People Working on Our Biggest Problems

We Need Our Brightest People Working on Our Biggest Problems | Venture Philanthropy - Translational Research | Scoop.it
A few weeks ago, I got to visit Microsoft’s annual conference of faculty members involved in computer science research at universities around the world. I hadn’t been able to attend the
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Morning Five: 5 biggest tech donors in 2013 - Waterbury Republican American

Morning Five: 5 biggest tech donors in 2013 Waterbury Republican American Google co-founder Sergey Brin and his wife, Anne Wojcicki (now separated) with $219 million to the Brin Wojcicki Foundation and to the Michael J.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

How the Innovation Investment Fund failed to innovate and contributed to the funding gap... plus a solution

How the Innovation Investment Fund failed to innovate and contributed to the funding gap... plus a solution | Venture Philanthropy - Translational Research | Scoop.it
There has been plenty written about the recent budget cuts affecting the innovative and entrepreneurial communities as part of the cutting of Commercialisation Australia and the Innovation Investment (How the Innovation Investment Fund failed to...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Zuckerberg's philanthropy proves school solutions aren't easy

Zuckerberg's philanthropy proves school solutions aren't easy | Venture Philanthropy - Translational Research | Scoop.it
The two-prong goal offers insight into Zuckerberg's evolution as an education philanthropist, one who continues to staunchly support innovation through a market-system menu of schools, but also one who is learning from mistakes and who realizes he...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Covance, NeoGenomics to Jointly Offer Services for Clinical Trials - GenomeWeb

Covance, NeoGenomics to Jointly Offer Services for Clinical Trials - GenomeWeb | Venture Philanthropy - Translational Research | Scoop.it
Covance, NeoGenomics to Jointly Offer Services for Clinical Trials GenomeWeb NEW YORK (GenomeWeb News) – Covance and NeoGenomics today announced a collaboration to jointly offer anatomic pathology and specialty laboratory testing services for...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Rohm and Haas appeals new trial for brain cancer plaintiff - Northwest Herald

Rohm and Haas appeals new trial for brain cancer plaintiff - Northwest Herald | Venture Philanthropy - Translational Research | Scoop.it
Rohm and Haas appeals new trial for brain cancer plaintiff Northwest Herald 18, 2013 4:21 p.m. CST. By KEVIN P. CRAVER - kcraver@shawmedia.com.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Los Angeles TV reporter Julie Chang is diagnosed with brain tumor after ... - New York Daily News

Los Angeles TV reporter Julie Chang is diagnosed with brain tumor after ... - New York Daily News | Venture Philanthropy - Translational Research | Scoop.it
New York Daily News Los Angeles TV reporter Julie Chang is diagnosed with brain tumor after ...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Mining billionaire Andrew Forrest to donate $65 million to higher education in Western Australia - ABC News (Australian Broadcasting Corporation)

Mining billionaire Andrew Forrest to donate $65 million to higher education in Western Australia - ABC News (Australian Broadcasting Corporation) | Venture Philanthropy - Translational Research | Scoop.it
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Social Entrepreneurship – Moving From Visionary to CEO Leader | The 7 Graces of Marketing - ethical marketing for social entrepreneurs

Social Entrepreneurship – Moving From Visionary to CEO Leader | The 7 Graces of Marketing - ethical marketing for social entrepreneurs | Venture Philanthropy - Translational Research | Scoop.it
RT @7GracesMarketng: Why the #7Graces Project CIC is not 'my idea' but my RESPONSIBILITY. http://t.co/m9Vgphr4wL #SocEnt
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

New Map of Insulin Pathway Could Lead to Better Diabetes Drugs - HealthCanal.com

New Map of Insulin Pathway Could Lead to Better Diabetes Drugs - HealthCanal.com | Venture Philanthropy - Translational Research | Scoop.it
New Map of Insulin Pathway Could Lead to Better Diabetes Drugs HealthCanal.com “The development of this insulin interaction map is unprecedented, and we expect it to lead us to new therapeutic approaches for type 2 diabetes,” said William E.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Petridish - Fund Science and Explore the World with Renowned Researchers

Petridish - Fund Science and Explore the World with Renowned Researchers | Venture Philanthropy - Translational Research | Scoop.it
Petridish lets you fund promising research projects and join first hand in new discoveries.
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

Translational Research Institute

Translational Research Institute | Venture Philanthropy - Translational Research | Scoop.it
Translational Research Institute (TRI) is a joint venture between The University of Queensland Diamantina Institute, Queensland University of Technology’s Institute of Health and Biomedical Innovation, Mater Research, and the Princess Alexandra...
more...
No comment yet.
Scooped by matthew kapp
Scoop.it!

The Orange County Brain Tumor Walk: Grey 4 Gandy - Unite to fight brain tumors

The Orange County Brain Tumor Walk: Grey 4 Gandy - Unite to fight brain tumors | Venture Philanthropy - Translational Research | Scoop.it
The Orange County Brain Tumor Walk (@britneyspears please help our fight against brain cancer http://t.co/dtzB9lYsRx #braincancer #grey4gandy http://t.co/lHeT5H7RMQ)...
more...
No comment yet.